FDA Approves New COVID-19 Vaccines for 2026-2027 Season; Medical Groups Issue Guidance

The FDA has approved updated COVID-19 vaccines from Moderna, Pfizer, and Novavax-Sanofi for the 2026-2027 season, targeting the JN.1 lineage XFG subvariant. With the CDC's Advisory Committee on Immunization Practices not having met, major medical societies have collaborated to issue their own recommendations for COVID-19, influenza, and RSV vaccines. This provides crucial guidance for the upcoming respiratory season, ensuring public health preparedness.